Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells
| Huvudupphovsmän: | , , , , , , |
|---|---|
| Materialtyp: | Conference item |
| Publicerad: |
American Thoracic Society
2018
|